StockTipsArenaBeta

BUY Tatva Chintan Pharma Chem Limited — Vaishali Parekh, Prabhudas Lilladher

BUYTatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem share price target & all analyst calls

byVaishali Parekh, Prabhudas LilladherHorizon: NA (inferred Swing (≤2wk))27 Aug 2026via Zee Business (Live)

Entry₹1,645Inferred
Target₹1,850
Total upside +12.46% (call closed)
Stop lossNot given
At expiry₹1,6809 Sept 2026, 3:30 pm
Expired+2.13%
Follow Vaishali Parekh for new calls(23% target hit, 82 closed calls)Get alertsWatch TATVA for new buy/sell callsGet alertsSee 108 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 9 Sept 2026
1 supporting1 neutral0 opposing
Supports the BUY call (1)

CRISIL Ratings has upgraded Tatva Chintan Pharma Chem Ltd's long-term rating from BBB+/Stable to A-/Stable and short-term rating from A2 to A2+.

BSE · Company Update·8 Sept · today

(opens in new tab)
Neutral / worth noting (1)

Tatva Chintan Pharma schedules AGM with ₹2 dividend proposal

NewsGoogle News·27 Aug · 2w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Tatva Chintan Pharma Chem

All analyst calls on Tatva Chintan Pharma Chem

More from Vaishali Parekh, Prabhudas Lilladher

Every call and its outcome